Verena Angerer
8PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 31, 2026
Acute toxicity of ADB-CHMINACA - a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome.Maren Hermanns-Clausen, Michaela Sommer, Annette Zschiesche
|Dec 06, 2023
Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study.Verena Angerer, Yasmin Schmid, Florian Franz
|Sep 08, 2022
Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids.Michaela J Sommer, Sebastian Halter, Verena Angerer
|Feb 21, 2019
Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM).Christina Grumann, Laura M Huppertz, Philippe Bisel
|Dec 23, 2018
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).Bjoern Moosmann, Philippe Bisel, Folker Westphal
|Oct 27, 2017
Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.Maren Hermanns-Clausen, Dieter Müller, Josephine Kithinji
Pageof 2
Frequent Collaborators
7 joint publications
Volker Auwärter
3 joint publications
Florian Eyer
2 joint publications
Maren Hermanns-Clausen
2 joint publications
Florian Franz
1 joint publications
Christa E Müller
1 joint publications
Dieter Müller
1 joint publications
Bjoern Moosmann
1 joint publications
Christina Grumann
1 joint publications
Laura M Huppertz
1 joint publications
Simon D Brandt
